Drawing for NANOFECT

USPTO serial 79135983

NANOFECT

Reviewed by CopyMark Law Group

Reg. 4541264Status 404
Filing date
Status date
Registration date
Jun 3, 2014
Examiner
DINALLO, KEVIN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NANOFECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GABRIELLE S. ROTH

GABRIELLE S. ROTH SUGHRUE MION, PLLC2100 PENNSYLVANIA AVENUE, N.W.WASHINGTON, DC 20037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents for non-medical chemical research use; chemical reagents for gene research use, other than for medical and veterinary use; chemical reagents for laboratory use which are used for introducing biological active substance such as peptide and nucleic acids into cells such as prokaryotic cells and eukaryotic cells, other than for medical and veterinary use; chemical reagents, other than for medical and veterinary use; polymers, used in the manufacture of medicine and pharmaceutical products; polymers, used in chemical, laboratory or medical research; chemicals for laboratory use, other than for medical and veterinary use; Chemicals, namely, polyethylene glycol-polyamino acid block copolymer which become raw materials for complex which combine with nucleic acid materials for introducing the nucleic acid materials into cells; chemicals, namely, polyethylene glycol-polyamino acid block copolymer which become raw materials for polymeric micelle preparations; chemicals for use in the manufacture of medicines; chemicals for industrial purposes; chemicals for scientific purposesSECTION 71 - CANCELLED—
005Reagents for medical and pharmaceutical research use; chemical reagents for medical purposes; anticancer drugs; anticancer preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; polymeric micelle anticancer drugs; polymeric micelle anticancer preparation; polymeric micelle pharmaceutical preparations and compositions for the treatment and prevention of cancer; polymeric micelle pharmaceutical preparations for RNA interference and for the treatment of cancer; anticancer drugs using polymers; anticancer preparations using polymers; pharmaceutical preparations and compositions using polymers for the treatment and prevention of cancer; pharmaceutical preparations using polymers for RNA interference and for the treatment of cancer; pharmaceutical preparations for RNA interference and for the treatment of cancer; medicines for human purposes for RNA interference and for the treatment of cancerSECTION 71 - CANCELLED—
042Research and developments of anticancer drugs and anticancer preparations; research and developments in the field of pharmaceutical technologies concerning polymeric micelle; research and development of pharmaceutical products and medical products; research and development in the pharmaceutical fields; testing, inspection or research of pharmaceuticalsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 30, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 17, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 8, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 8, 2022INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Jun 3, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 14, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 27, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 27, 2014FIMPFINAL DISPOSITION PROCESSED—
Sep 25, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 3, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 30, 2014CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jul 24, 2014CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 26, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 3, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 18, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 18, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2014GPNXNOTIFICATION PROCESSED BY IB—
Feb 26, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 26, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 12, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 12, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Feb 12, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 12, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 12, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 7, 2014DOCKASSIGNED TO EXAMINER—
Jan 28, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2014ALIEASSIGNED TO LIE—
Jan 2, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2013RFNTREFUSAL PROCESSED BY IB—
Oct 4, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 2, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 2, 2013RFRRREFUSAL PROCESSED BY MPU—
Oct 2, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 1, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2013DOCKASSIGNED TO EXAMINER—
Sep 30, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 27, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance